3:52 PM
 | 
Aug 22, 2018
 |  BC Extra  |  Financial News

Biosimilars company Mabpharm sets sights on Hong Kong IPO

Mabpharm Ltd. (Taizhou, China) proposed Wednesday to list on the Hong Kong Exchanges and Clearing Ltd. (HKEX) in an IPO underwritten by CICC.

Mabpharm is the second biotechnology company this week to file to list on HKEX; Ascentage Pharma Group International (Suzhou, China) filed on Monday (see “Ascentage Hops in Hong Kong IPO Queue”).

Mabpharm's pipeline contains...

Read the full 267 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >